Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE et al (2009) Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114(8):1537–1544

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bagchi S, Yuan R, Engleman EG (2021) Immune Checkpoint inhibitors for the treatment of Cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16:223–249

Article  PubMed  CAS  Google Scholar 

Bai D-S, Zhang C, Chen P, Jin S-J, Jiang G-Q (2017) The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep 7(1):12870

Article  PubMed  PubMed Central  Google Scholar 

Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236

Article  PubMed  Google Scholar 

Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022

Article  PubMed  Google Scholar 

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248–262

Article  PubMed  CAS  Google Scholar 

Chen H, Zhang H, Cao L, Cui J, Ma X, Zhao C et al (2022) Glucose limitation sensitizes Cancer cells to Selenite-Induced cytotoxicity via SLC7A11-Mediated Redox Collapse. Cancers (Basel). 14(2)

De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H et al (2011) Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208(3):469–478

Article  PubMed  PubMed Central  Google Scholar 

Drake CG, Jaffee E, Pardoll DM (2006) Mechanisms of immune evasion by tumors. Adv Immunol 90:51–81

Article  PubMed  CAS  Google Scholar 

Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D et al (2017) Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 66(3):545–551

Article  PubMed  CAS  Google Scholar 

EASL-EORTC clinical (2012) Practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943

Article  Google Scholar 

El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C et al (2017) Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 389(10088):2492–2502

Article  PubMed  PubMed Central  CAS  Google Scholar 

Foerster F, Gairing SJ, Ilyas SI, Galle PR (2022) Emerging immunotherapy for HCC: a guide for hepatologists. Hepatology 75(6):1604–1626

Article  PubMed  Google Scholar 

Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391(10127):1301–1314

Article  PubMed  Google Scholar 

Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192(7):1027–1034

Article  PubMed  PubMed Central  CAS  Google Scholar 

Furbert-Harris PM, Parish-Gause D, Hunter KA, Vaughn TR, Howland C, Okomo-Awich J et al (2003) Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells. Cell Mol Biol (Noisy-le-grand) 49(7):1009–1016

PubMed  CAS  Google Scholar 

Gong L, Huang D, Shi Y, Liang Za, Bu H (2023) Regulated cell death in cancer: from pathogenesis to treatment. Chin Med J (Engl) 136(6):653–665

Article  PubMed  CAS  Google Scholar 

Grisaru S, Itan M, Munitz A (2021) Analysis of mouse Eosinophil Migration and Killing of Tumor cells. Methods Mol Biol 2241:89–97

Article  PubMed  CAS  Google Scholar 

Hänzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7

Article  PubMed  PubMed Central  Google Scholar 

Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M et al (2005) Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65(3):1089–1096

Article  PubMed  CAS  Google Scholar 

Ishida Y, Agata Y, Shibahara K, Honjo T (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11(11):3887–3895

Article  PubMed  PubMed Central  CAS  Google Scholar 

Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A 99(19):12293–12297

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B et al (2017) Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. J Natl Cancer Inst. 109(9)

Joly JH, Delfarah A, Phung PS, Parrish S, Graham NA (2020) A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose. J Biol Chem 295(5):1350–1365

Article  PubMed  Google Scholar 

Kataoka S, Konishi Y, Nishio Y, Fujikawa-Adachi K, Tominaga A (2004) Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. DNA Cell Biol 23(9):549–560

Article  PubMed  CAS  Google Scholar 

Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of tumor escape phenotypes. Nat Immunol. 3(11)

Krummel MF, Allison JP (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182(2):459–465

Article  PubMed  CAS  Google Scholar 

Lee Y-T, Fujiwara N, Yang JD, Hoshida Y (2023) Risk stratification and early detection biomarkers for precision HCC screening. Hepatology 78(1):319–362

Article  PubMed  Google Scholar 

Liu Y, Zheng P (2020) Preserving the CTLA-4 checkpoint for Safer and more effective Cancer immunotherapy. Trends Pharmacol Sci. 41(1)

Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X et al (2020) Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 22(4):476–486

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25(3):404–414

Article  PubMed  PubMed Central  CAS  Google Scholar 

Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M et al (2016) Hepatocellular carcinoma. Nat Rev Dis Primers 2:16018

Article  PubMed  Google Scholar 

Locy H, de Mey S, de Mey W, De Ridder M, Thielemans K, Maenhout SK (2018) Immunomodulation of the Tumor Microenvironment: turn foe into friend. Front Immunol 9:2909

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM et al (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138(2):493–502

Article  PubMed  CAS  Google Scholar 

Lucarini V, Ziccheddu G, Macchia I, La Sorsa V, Peschiaroli F, Buccione C et al (2017) IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils. Oncoimmunology 6(6):e1317420

Article